When Gene Marrazzo was announced as director of the National Institute of Allergy and Infectious Diseases (NIAID) last year, he became one of the world's leading public health policymakers, and the responsibilities are heavier than ever before for the institute's new director, who will succeed Anthony Fauci, who held the position during the coronavirus pandemic and became a household name.
After decades of working on HIV prevention and sexually transmitted diseases, as well as overseeing COVID-19 treatment interventions, Marrazzo is now responsible for NIAID's $6.6 billion annual budget and the future of infectious disease control in the United States.
This includes working with the institute's 21 laboratories across the country, leading the fight against Ebola and HIV, and spearheading the development of new vaccines, treatments, diagnostics and technologies.
Top of Marrazzo's to-do list is tackling antimicrobial resistance (AMR), or drug-resistant superbugs, which are predicted to cause 10 million deaths a year and cost the global economy $1 trillion annually by 2050. In May, Britain's former chief medical officer warned that the rise of these pathogens could make pandemics seem “small” and that the problem is more serious than climate change.
Global warming is one of the factors contributing to the increase in drug-resistant bacteria, and changes in the climate conditions on Earth Salmonella Causes cholera Biblio To survive, we'll need to avoid our current antibiotic arsenal altogether. Here, Marrazzo outlines what we should probably fear most, and some developments we can expect in the near future.
Charlotte Lytton: In what ways…
Source: www.newscientist.com